Cresilon Raises $25M for Instant Hemostatic Gel

A recent Vegconomist article discussed a revolutionary wound treatment that has attracted significant investment for further development. The product is Cresilon’s plant-based hemostatic gel called VETIGEL. The company just closed a Series A-4 round of financing to the tune of $25 million. The gel has been used in veterinary applications for both emergency care and surgical procedures.